In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...

Using patent intelligence data from the FounderNest platform, Gonzalez highlights where small-molecule synthesis, formulation ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

Expertise in CMC (chemistry, manufacturing, and control) ensures the appropriate manufacture of a pharmaceutical or biologic by coordinating material characterization, formulation development, and ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...

"Our vision is to turn the world's most powerful photosynthetic cell into a platform for scalable drug production that could one day be in every city. Partnering with Persist AI gives us the robotic ...

DFE Pharma launches continuous manufacturing platform to accelerate and enable formulation development: Goch, Germany Wednesday, February 18, 2026, 12:00 Hrs [IST] DFE Pharma, a g ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Researchers in Japan have reported a solvent-free technique that uses heat and vacuum to convert poorly soluble drugs into more bioavailable amorphous forms, addressing a central bottleneck in ...